InsidersTradesSigma
Follow the SB성보 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, SB성보 has published 47 reports. Market capitalisation: €5.3bn. The latest transaction was filed on 30 June 2026 (Other). Among the most active insiders: 윤정선. The full history is free.
Analysts rate SB성보 Buy (bullish), based on 8 analysts. Average price target: €42.88.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
25 of 47 declarations
SB성보 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market.